These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 32555117)

  • 1. In brief: Trijardy XR - a new 3-drug combination for Type 2 diabetes.
    Med Lett Drugs Ther; 2020 Jun; 62(1599):88. PubMed ID: 32555117
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.
    Lingvay I; Beetz N; Sennewald R; Schuler-Metz A; Bertulis J; Loley C; Lang B; Lippert C; Lee J; Manning LS; Terada D
    Postgrad Med; 2020 May; 132(4):337-345. PubMed ID: 32366156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyxambi--a new combination for type 2 diabetes.
    Med Lett Drugs Ther; 2015 Apr; 57(1467):65-6. PubMed ID: 25897551
    [No Abstract]   [Full Text] [Related]  

  • 4. Empagliflozin/linagliptin single-pill combination therapy for patients with type 2 diabetes mellitus.
    Jain RK
    Expert Opin Pharmacother; 2017 Apr; 18(6):545-549. PubMed ID: 28375658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empagliflozin/Linagliptin: Combination therapy in patients with type 2 diabetes.
    Tan X; Hu J
    Ann Endocrinol (Paris); 2016 Oct; 77(5):557-562. PubMed ID: 27062036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empagliflozin/Linagliptin: A Review in Type 2 Diabetes.
    Kim ES; Deeks ED
    Drugs; 2015 Sep; 75(13):1547-57. PubMed ID: 26323340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapagliflozin/saxagliptin (Qtern) for type 2 diabetes.
    Med Lett Drugs Ther; 2018 Mar; 60(1543):55-56. PubMed ID: 29635266
    [No Abstract]   [Full Text] [Related]  

  • 8. [New fixed combination in type 2 diabetes].
    Red
    MMW Fortschr Med; 2016 Apr; 158(7):74. PubMed ID: 27071602
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.
    Forst T; Falk A; Andersen G; Fischer A; Weber MM; Voswinkel S; Heise T; Kapitza C; Plum-Mörschel L
    Diabetes Obes Metab; 2017 Apr; 19(4):489-495. PubMed ID: 28009472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials.
    DeFronzo RA; Lee C; Kohler S
    Adv Ther; 2018 Jul; 35(7):1009-1022. PubMed ID: 29949041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes.
    Gallwitz B
    Expert Opin Drug Saf; 2017 Dec; 16(12):1399-1405. PubMed ID: 28934557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for type 2 diabetes.
    Med Lett Drugs Ther; 2019 Nov; 61(1584):169-178. PubMed ID: 31770362
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes.
    Rizos CV; Filippatos TD; Elisaf MS
    Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):117-125. PubMed ID: 29241374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empagliflozin/metformin (Synjardy) for type 2 diabetes.
    Med Lett Drugs Ther; 2015 Dec; 57(1484):172-4. PubMed ID: 26670554
    [No Abstract]   [Full Text] [Related]  

  • 15. Empagliflozin/linagliptin single-tablet combination: first-in-class treatment option.
    Woo V
    Int J Clin Pract; 2015 Dec; 69(12):1427-37. PubMed ID: 26303997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-pill combination therapy for type 2 diabetes mellitus: linagliptin plus empagliflozin.
    Aronson R
    Curr Med Res Opin; 2015 May; 31(5):901-11. PubMed ID: 25775379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials.
    Watada H; Yamauchi T; Yamamoto F; Taniguchi A; Yarush L; Heilmann C; Yasui A
    Expert Opin Drug Saf; 2020 Sep; 19(9):1193-1202. PubMed ID: 32552153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for type 2 diabetes.
    Med Lett Drugs Ther; 2022 Nov; 64(1663):177-184. PubMed ID: 36384763
    [No Abstract]   [Full Text] [Related]  

  • 19. [The SGLT2 inhibitor empagliflozin: results of EMPA-REG OUTCOMER trial].
    Okamura T; Koiwai K
    Nihon Yakurigaku Zasshi; 2016; 148(5):282. PubMed ID: 27803444
    [No Abstract]   [Full Text] [Related]  

  • 20. [XIGDUO - fixed combination of the active ingredients dapagliflozin and metformin].
    Edelsberger T
    Vnitr Lek; 2016 Mar; 62(3):199-201. PubMed ID: 27180669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.